Expert Pharmacy Insights

Budesonide with Formoterol Inhalers: Doses, MART and What the Trials Show

Budesonide with formoterol is the only inhaled steroid and long-acting beta agonist combination that can serve as both preventer and reliever. SYGMA 1 cut severe exacerbations from 0.20 to 0.07 per year on 17 percent of the steroid dose, and the CARE trial in children reported 0.23 versus 0.41 attacks per year against salbutamol. This guide covers the trial numbers, strength conventions across Foracort and Symbicort, device choice and where the combination is the wrong answer.